Kidney Week

Abstract: SA-PO0453

Diabetic Kidney Disease Screening at a Tertiary Academic Center

Session Information

• CKM: Clinical - Screening, Population Management, Care Disparities, and Patient-Centered Outcomes
  October 24, 2026 | Location: Exhibit Hall A, Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category: Cardiovascular-Kidney-Metabolic Health

• 602 Cardiovascular-Kidney-Metabolic Health: Clinical

Authors

• Kowalczyk, Nicholas Stanley, The University of Chicago, Chicago, Illinois, United States

Nicholas Stanley Kowalczyk, MD

• McGill, Rita L., The University of Chicago, Chicago, Illinois, United States

Rita L. McGill, MD, MS, FASN

• Tiro, Jasmin A., The University of Chicago, Chicago, Illinois, United States

Jasmin A. Tiro, PhD, MPH

• Laiteerapong, Neda, The University of Chicago, Chicago, Illinois, United States

Neda Laiteerapong, MD, MS

• Saunders, Milda R., The University of Chicago, Chicago, Illinois, United States

Milda R. Saunders, MD, MPH

Background

Yearly screening with eGFR and UACR for patients with type 2 diabetes mellitus (T2DM) is recommended, however, prior studies have demonstrated that screening remains suboptimal.

Methods

We retrospectively examined the prevalence of annual diabetic kidney disease (DKD) screening among adults with T2DM receiving primary, nephrology or endocrinology care using EHR data at an urban academic tertiary medical center from 2020-2025. We used multivariable logistic regression models to identify patient and provider-level correlates of screening.

Results

The average rate of screening for DKD with both eGFR and UACR was 42.9%. Black (OR 1.22), Hispanic (OR 1.29), and other races (OR 1.23) were associated with higher rates compared to White (all p<0.05). Compared to patients 65-79 years old, those 18-44 years (OR 0.78) and 80+ years (OR 0.70) were significantly less likely to be screened (all p<0.05). Patients with Medicaid (OR 0.70; p<0.001) were less likely to be screened people with private insurance. People with BMI≧25 (OR 1.15; p=0.003) or HTN (OR 1.25;p<0.001) were more likely to be screened, while people who smoked (OR 0.81; p=0.01), had a history of CVA (OR 0.69; p<0.001), or CHF (OR 0.75; p<0.001) were less likely. A history of screening in the prior year (p<0.001), or a history of an endocrinology (p<0.001) or nephrology (p<0.001) visit were associated with a higher rates.

Conclusion

Screening remains suboptimal particularly in young patients, patients with Medicaid, and patients with a history of smoking, CVA, or CHF.

Figure 1

Table 1

Funding

• NIDDK Support